Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Filings indexed 371 across all filing types
Latest filing 2021-03-22 Declaration of Voting R…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과), detailing the approval of financial statements, dividend resolutions, board/management appointments, and changes to business objectives. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion, key financial data, and financial ratios for the fiscal year. While it contains financial information, it is a standard regulatory disclosure form used to announce the receipt and submission of the audit report to the exchange, rather than the full, multi-page audit report document itself. Therefore, it fits the 'Audit Report / Information' category as it provides the core audit results and financial summary. FY 2020
2021-03-12 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Jeonjin BioPharm Co., Ltd. for the fiscal year ending December 31, 2020. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis (MD&A) or business overview typically found in a full 10-K, and it is not an Earnings Release (ER) as it is a comprehensive audited financial document. FY 2020
2021-03-12 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Solicitation of Proxy' (의결권대리행사권유참고서류) filed by a shareholder (Lee Sung-woo) for the upcoming Annual General Meeting of Jeonjin Bio Pharm. It contains the purpose of the solicitation, details of the proxy solicitor, and information regarding the proposed director and auditor candidates. This document is a formal proxy solicitation material used to request shareholder votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-10 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Solicitation of Proxy' (의결권대리행사권유참고서류) filed by a shareholder (Lee Sung-woo) for the upcoming Annual General Meeting of Jeonjin Bio-Pharm. It contains specific details regarding the solicitation of votes, the purpose of the solicitation (challenging current management), and the list of proposed director and auditor candidates. This falls under the category of Proxy Solicitation & Information Statement.
2021-03-10 Korean
[기재정정]소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from a Korean company (Jeonjin BioPharm) regarding a court decision on a lawsuit ('주주명부 열람 및 등사가처분' - Shareholder Register Inspection and Copying Injunction). It details a correction to a previous filing regarding the court's decision. Since it pertains to legal proceedings and court rulings, it falls under the 'Legal Proceedings Report' category.
2021-03-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.